Forbion Growth Opportunities Fund III Cooperatief U.A.
SEC CIK 2050895 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BRVE | Braveheart Bio, Inc. | 10% | 9.72M | $64.80M | — | 4 | 2026-08-07 | 2026-08-07 |
Most active insiders at BRVE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Forbion Growth Opportunities Fund III Cooperatief U.A. | 10% | $64.80M | — |
| 2 | Chimovits Erez | Dir, 10% | $34.92M | — |
| 3 | ORBIMED ADVISORS LLC | Dir, 10% | $34.92M | — |
| 4 | AH Bio Fund IV, L.P. | 10% | $19.80M | — |
| 5 | Murdoch Travis | CEO, Pres, Dir | $1.50M | — |
| 6 | Viehbacher Christopher | Dir | $1.50M | — |
| 7 | Lubner David Charles | Dir | $1000.0K | — |
| 8 | Rickey James Paul | CFO | $500.0K | — |
| 9 | Malek David I | Dir | $75.0K | — |
| 10 | Anderson Michele A. | Chief Development Off | $20.0K | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-07 17:25 | 2026-08-07 | BRVE | Braveheart Bio, Inc. | Forbion Growth Opportunities Fund III Cooperatief U.A. | 10% | C - Cnv Deriv | $0.00 | +9.13M | 9.72M | +1,553% | $0 |
| DI | 2026-08-07 17:25 | 2026-08-07 | BRVE | Braveheart Bio, Inc. | Forbion Growth Opportunities Fund III Cooperatief U.A. | 10% | C - Cnv Deriv | $0.00 | +7.99M | 8.51M | +1,553% | $0 |
| D | 2026-08-07 17:25 | 2026-08-07 | BRVE | Braveheart Bio, Inc. | Forbion Growth Opportunities Fund III Cooperatief U.A. | 10% | P - Purchase | $18.00 | +1.92M | 11.64M | +20% | +$34.56M |
| DI | 2026-08-07 17:25 | 2026-08-07 | BRVE | Braveheart Bio, Inc. | Forbion Growth Opportunities Fund III Cooperatief U.A. | 10% | P - Purchase | $18.00 | +1.68M | 10.19M | +20% | +$30.24M |
Purchase Sale Sale after option exercise All abbreviations